2Bruyn CD, Delforge A, Lgneaux L,et al. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. Bone Marrow Transplant, 2000,25:377-383.
3CardosoJA, Li ML, Batard P, et al.Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA,1993,90:8707-8711.
4Gluckman E. Hematopoietic stem cells tramplants using umbilical cord bloock NEngl Med, 2001,344:1860-1861.
5Ballen K, Broxmeyer HE, McCul-loughJ, et al. Current status of cord blood banking and transplanttion in the United states and Europe. Bio Blood Marrow Transplant, 2001,7(12):635-645.
6Gluckman E, tLocha V, Chevret S.Results of unrelated umbilical cord blood hematopoietic stem cell trartsplant.Transfus Clin Biol. 2001,8(3): 146-154.
7Kanamaru S, Kawano Y, Watanabe T, et al. Low numbers of megakary-ocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.Stem Cells, 2000,18:190-195.
8Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human unbilical cord blood T lymphocytes. Proc Natl Acad Sci USA, 1992,89:10006-10010.
5Wagner JE, Kurtzberg J. Allogeneic umbilical cord blood transplantation. In:Broxmeyer HE Ed. Cellular characteristericsof cord blood and cord blood transplantation[ M ]. Bethesda:AABB Press, 1998,113 - 146.
6Rocha V,Wagner JE Jr, Sobocinski KA, et al. Graft- versus -host disease in children who have received a cordblood or bone marrow transplantat from an HLA -identical sibling[J]. N Engl J Med,2000, 342(25) : 1846 - 1854.
7Rubinstein P,Stevens CE. Placental bloodfor bone marrow replacement: the NewYork Blood Center's program and clinical results[ J ]. Baillieres Best Pract Res Clin Haematol,2000,13 (4) :565.
8Wanger J E, BarkerJN, DeFor TE, et al. Tansplantationof unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases:infuluence of CD34 cell dose and HLA disparity on treatment2related mortality and survival[ J]. Blood ,2002,100 ( 5 ) : 1611.
9Laporte JP, Gorin NC, Rubinstein P, et al. Cord blood transplantation from an unrelated donor in a adult with chronic myelogenenous leukemia [J]. N Engl J Med,1996,335 (3) :167.
10Langhlin M J, Barker J, Bumback B, et al. Hematopoietic engraftment and survival in adult recipient of umbilica cord blood from unrelated donors [J]. N En gl J Med,2001,344(24) :1815 -1822.
